NovoCure Limited has grown revenue 11% a year over three years and 5.1% a year over five. Revenue growth, 3-year annual rate: +11% (Medical Devices median +12%). Revenue growth, 5-year rate: +5.1%, growth has picked up over the last three years. Years of annual history on file: 13, FY2013 to FY2025, as filed.

NVCRNovoCure Limited

Healthcare

$14.58+15% 1Y

$14.58

$10.0352 weeks$20.00

Latest close: back above its 200-day averageOct 9, 2026what changed →

Is it growing?

Good

Growing: revenue growing +11% year on year and operating margin widening (+5.0 points).

2 good, 1 without data

Revenue trend+11% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Margin direction+5.0 points operating

Trailing-twelve-month operating margin, -22.3% now against -27.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is NVCR growing?

NovoCure Limited has grown revenue 11% a year over three years and 5.1% a year over five.

+11%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.1%
Revenue growth, 5-year rate · +11% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›